Alternate pathways yield new antibiotics

An article in The Scientist reports a UB research team has manipulated E. coli to produce 40 new versions of the antibiotic erythromycin, including three that show promise in fighting drug-resistant bacteria. The article quotes Blaine Pfeifer, associate professor of chemical and biological engineering in the School of Engineering and Applied Sciences, who said, “We’re trying to come up with new antibiotics that can overcome resistance, and we see this as an important step forward.” Articles also appeared on news outlets that include The Australian, International Business Times, Medical News Today, MSN, Business Standard, Science Newsline, Science Daily, Fox News, Nanowerk, Phys Org and KTLA-TV in Los Angeles.

Read more:

http://www.the-scientist.com/?articles.view/articleNo/43110/title/Alternate-Pathways-Yield-New-Antibiotics/

http://www.theaustralian.com.au/news/health-science/ecoli-manipulated-to-stop-antibiotic-from-becoming-ineffective/story-e6frg8y6-1227377208821

http://www.ibtimes.co.uk/e-coli-turned-into-factories-make-new-versions-antibiotic-1503816

http://www.msn.com/en-in/news/other/engineered-e-coli-to-fight-antibiotic-resistant-bacteria/ar-BBkrSBi

http://www.foxnews.com/health/2015/05/29/e-coli-could-be-answer-to-antibiotic-resistant-bacteria-scientists-say/